Difesa Capital Management’s Cellectar Biosciences CLRB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-333	Closed	-$34K	–	240
2022 Q3	$34K	Buy	333 +300	+909%	+$30.6K	0.02%	129
2022 Q2	$40K	Hold	33	–	–	0.02%	126
2022 Q1	$7K	Hold	33	–	–	﹤0.01%	220
2021 Q4	$7K	Buy	+33	New	+$7K	﹤0.01%	216